Is self-sufficiency financially viable and ethically justifiable?--legal aspects.
There is no legislation specifically designed to compensate haemophilia patients who have been damaged by defective blood products. But there is a general regime, created as a result of the thalidomide tragedy, which deals with defective 'products'. It was introduced at the European level by the European Directive on Product Liability in 1985 and has been given effect in England by the Consumer Protection Act 1987. The rights of haemophilia patients who are injured by defective blood products depends on this Directive.
Newdick
C
C
Department of Law, University, Reading, UK.
D001798:Blood Proteins / Q000009:adverse effects / Q000191:economics / Q000600:supply & distribution*; D002648:Child; D004992:Ethics, Medical; D015658:HIV Infections / Q000517:prevention & control / Q000635:transmission; D006467:Hemophilia A / Q000628:therapy; D006801:Humans; D007049:Iatrogenic Disease; D007603:Jurisprudence; D007883:Legislation, Medical; D008297:Male; D012306:Risk; D012449:Safety; D013812:Therapeutics / Q000191:economics
D001798:Blood Proteins